Loading…
Housing for All Act of 2022
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Housing for All Act of 2022 This bill modifies existing, and creates new, grants and programs concerning affordable housing and homelessness. In particular, the bill authorizes federal funding of the Housing Trust Fund, which supports affordable housing activities. Currently, contributions to the fund come from the earnings of Fannie Mae and Freddie Mac. Additionally, the bill (1) expands eligibility for housing choice vouchers, which provide rental assistance to low-income individuals; and (2) entitles certain individuals to the vouchers. Other matters addressed in the bill include permanently authorizing the U.S. Interagency Council on Homelessness (which terminates on October 1, 2028) and modifying existing programs that support housing for the elderly, individuals with disabilities, and individuals experiencing homelessness or at risk of homelessness. The bill also creates various housing-related grant programs to, for example, support overnight parking for individuals who live in vehicles and no-cost legal assistance with evictions for low-income individuals. The bill also incorporates housing into certain transportation grants and programs.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2026 · third_quarter · Health Issues
Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act HR 7391 Community Health Center Drug Pricing Protection Act HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act (Reconciliation 2.0) S 3014 Ensuring Timely Access to Generics Act of 2025 S 2355 Patients Deserve Price Tags Act HR 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 HR 8800 National Defense Authorization Act for Fiscal year 2027 HR 9102 BINSA Bill COINS Act, enacted within P.L. 119-60 National Defense Authorization Act for Fiscal Year 2026 S 1414 Expedited Access to Biosimilars Act HR 10628/ S 5571 Biosimilars Access and Affordability Act S 5244 Sustain 340B Act HR 9599 Secure 340B Act HR 5509/ S 2903 Safe Step Act
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. (Sponsor introductory remarks on measure: CR S1062)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $3,150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Health Issues
Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act HR 7391 Community Health Center Drug Pricing Protection Act HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act (Reconciliation 2.0) S 3014 Ensuring Timely Access to Generics Act of 2025 S 2355 Patients Deserve Price Tags Act HR 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 HR 8800 National Defense Authorization Act for Fiscal year 2027 HR 9102 BINSA Bill COINS Act, enacted within P.L. 119-60 National Defense Authorization Act for Fiscal Year 2026 S 1414 Expedited Access to Biosimilars Act
Client expense: $2,440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Health Issues
Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act H.R.5526 Biosimilar Red Tape Elimination Act HR 7391 Community Health Center Drug Pricing Protection Act
Client expense: $2,580,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Housing
H.R. 7049 Mortgage Borrower Protection Act of 2022 H.R. 7735 Improving Access to the VA Home Loan Benefit Act of 2022 S. 4208 Improving Access to the VA Home Loan Benefit Act of 2022 S. 1838 Building Credit Access for Veterans Act of 2022 S. 3788 Housing for All Act of 2022 S. 3941 Housing Supply Expansion Act H.R. 8235 Housing Supply Expansion Act S. 4445 Affordable Housing Bond Enhancement Act S.4737 Housing Market Transparency Act S.4872 Strategy and Investment in Rural Housing Preservation Act of 2022 FHA MIP reduction, servicing standards, and other FHA program issues. S. 4789Expand Housing Opportunities Act Government Sponsored Enterprises LLPAs, counterparty risk, capital rules, Reps and Warrants CFPB Mortgage Rules
Client expense: $570,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of
2022 · third_quarter · Housing
H.R. 2543 Financial Services Racial Equity, Inclusion, and Economic Justice Act H.R. 2553 Real Estate Valuation Fairness and Improvement Act of 2021 H.R. 3009 Improving Language Access in Mortgage Servicing Act H.R. 3172 HELPER Act H.R. 4155 Green Neighborhoods Act of 2021 H.R. 4495 Downpayment Toward Equity Act of 2022 H.R. 4657 Veteran Home Energy Savings Act H.R. 5915 FHA Fairness Act H.R. 7049 Mortgage Borrower Protection Act of 2022 H.R. 7735 Improving Access to the VA Home Loan Benefit Act of 2022 S. 4208 Improving Access to the VA Home Loan Benefit Act of 2022 S. 1838 Building Credit Access for Veterans Act of 2022 S. 3788 Housing for All Act of 2022 S. 3941 Housing Supply Expansion Act H.R. 8235 Housing Supply Expansion Act S. 4445 Affordable Housing Bond Enhancement Act S.4737 Housing Market Transparency Act S.4872 Strategy and Investment in Rural Housing Preservation Act of 2022 FHA MIP reduction, servicing standards, and other FHA program issues. GNMA Issuer Eligibility standards FHFA Capital and Liquidity Standards for IMBs GSE condo project guidelines
Client expense: $520,000 · Firm income: Not reported
Government targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
2022 · third_quarter · Housing
Support Housing for All Act, S. 3788 related to affordable housing programs.
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2022 · second_quarter · Housing
H.R. 2543Financial Services Racial Equity, Inclusion, and Economic Justice Act H.R. 3009Improving Language Access in Mortgage Servicing Act H.R. 3172HELPER Act H.R. 4155Green Neighborhoods Act of 2021 H.R. 4495 Downpayment Toward Equity Act of 2022 H.R. 4657Veteran Home Energy Savings Act H.R. 5915FHA Fairness Act H.R. 7049Mortgage Borrower Protection Act of 2022 H.R. 7735Improving Access to the VA Home Loan Benefit Act of 2022 S. 1838 Building Credit Access for Veterans Act of 2022 S. 3788 Housing for All Act of 2022 S. 3941 Housing Supply Expansion Act H.R. 8235Housing Supply Expansion Act S. 4445 Affordable Housing Bond Enhancement Act FHFA Prudential Standards for IMBs Enterprise Equitable Housing Finance Plans FHFA UMBS Fee CFPB matters related to QM rule Special purpose credit programs (SPCPs) Unfair, Deceptive, or Abusive Acts or Practices (UDAAPs) HUD Issues related to FHA Servicing matters Mortgage Insurance Premium Handbook revisions
Client expense: $860,000 · Firm income: Not reported
2022 · second_quarter · Housing
Support of affordable housing policies, Housing for All Act, S. 3788.
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2022 · first_quarter · Housing
H.R. 5376 - Build Back Better Act H.R. 3009 - Improving Language Access in Mortgage Servicing Act of 2021 S. 3788 - Housing for All Act of 2022 S. 1860 - Lead-Safe Housing for Kids Act of 2021
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Consumer Financial Protection Bureau (CFPB), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE